Mary Lor

1.5k total citations
23 papers, 319 citations indexed

About

Mary Lor is a scholar working on Immunology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Mary Lor has authored 23 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 8 papers in Infectious Diseases and 7 papers in Epidemiology. Recurrent topics in Mary Lor's work include Immune Cell Function and Interaction (6 papers), HIV Research and Treatment (5 papers) and Hematopoietic Stem Cell Transplantation (5 papers). Mary Lor is often cited by papers focused on Immune Cell Function and Interaction (6 papers), HIV Research and Treatment (5 papers) and Hematopoietic Stem Cell Transplantation (5 papers). Mary Lor collaborates with scholars based in Australia, China and Denmark. Mary Lor's co-authors include Lucie Leveque, Bianca E. Teal, David Harrich, Kelli P. A. MacDonald, Geoffrey R. Hill, Rachel D. Kuns, Katie E. Lineburg, Steven Lane, Neil C. Raffelt and Stuart D. Olver and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Blood.

In The Last Decade

Mary Lor

22 papers receiving 313 citations

Peers

Mary Lor

IMMUN

HEMAT

EPIDE

Neelima Choudhary United States

Jae‐A Han South Korea

Ji‐Hun Lim South Korea

Carolyn E. Rydyznski United States

Chen‐Hsuan Ho Taiwan

A Yeh United States

Lena Kask Sweden

Stacey Cranert United States

Michael S. O’Keeffe United States

E. Lake Potter United States

Neelima Choudhary United States

Mary Lor

180 ×1.1

IMMUN

56 ×0.7

16 ×0.3

HEMAT

18 ×0.3

36 ×0.8

EPIDE

Citations per year, relative to Mary Lor Mary Lor (= 1×) peers Neelima Choudhary

Countries citing papers authored by Mary Lor

Since Specialization

Citations

This map shows the geographic impact of Mary Lor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Lor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Lor more than expected).

Fields of papers citing papers by Mary Lor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Lor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Lor. The network helps show where Mary Lor may publish in the future.

Co-authorship network of co-authors of Mary Lor

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Lor. A scholar is included among the top collaborators of Mary Lor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Lor. Mary Lor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lor, Mary, et al.. (2025). Robust and consistent bonding of polydimethylsiloxane to polystyrene cell culture plates. APL Materials. 13(1).

Ullah, Md Ashik, Sonja Rittchen, Jia Li, et al.. (2024). Dual therapy with corticosteroid ablates the beneficial effect of DP2 antagonism in chronic experimental asthma. Nature Communications. 15(1). 10253–10253. 1 indexed citations

Stewart, Romal, Kexin Yan, Troy Dumenil, et al.. (2023). SARS-CoV-2 omicron BA.5 and XBB variants have increased neurotropic potential over BA.1 in K18-hACE2 mice and human brain organoids. Frontiers in Microbiology. 14. 1320856–1320856. 19 indexed citations

Wang, Peiyu, Renwu Zhou, Rusen Zhou, et al.. (2022). Cold atmospheric plasma for preventing infection of viruses that use ACE2 for entry. Theranostics. 12(6). 2811–2832. 20 indexed citations

Yan, Kexin, Thuy T. Le, Alberto A. Amarilla, et al.. (2022). Monoclonal Antibodies Specific for SARS-CoV-2 Spike Protein Suitable for Multiple Applications for Current Variants of Concern. Viruses. 15(1). 139–139. 9 indexed citations

Krycer, James R., Mary Lor, Rebecca L. Fitzsimmons, & James E. Hudson. (2021). A cell culture platform for quantifying metabolic substrate oxidation in bicarbonate-buffered medium. Journal of Biological Chemistry. 298(2). 101547–101547. 1 indexed citations

Lin, Min‐Hsuan, Daniel J. Rawle, Lu Wang, et al.. (2021). Dengue virus-free defective interfering particles have potent and broad anti-dengue virus activity. Communications Biology. 4(1). 557–557. 14 indexed citations

Li, Dongsheng, Daniel J. Rawle, Min‐Hsuan Lin, et al.. (2019). eEF1A demonstrates paralog specific effects on HIV-1 reverse transcription efficiency. Virology. 530. 65–74. 11 indexed citations

Rawle, Daniel J., Dongsheng Li, Lu Wang, et al.. (2019). Oxazole-Benzenesulfonamide Derivatives Inhibit HIV-1 Reverse Transcriptase Interaction with Cellular eEF1A and Reduce Viral Replication. Journal of Virology. 93(12). 9 indexed citations

10.

Li, Dongsheng, et al.. (2018). Differential Effects of Strategies to Improve the Transduction Efficiency of Lentiviral Vector that Conveys an Anti-HIV Protein, Nullbasic, in Human T Cells. Virologica Sinica. 33(2). 142–152. 5 indexed citations

11.

Li, Dongsheng, Ting Wei, Mary Lor, et al.. (2018). The eukaryotic translation elongation factor 1A regulation of actin stress fibers is important for infectious RSV production. Virology Journal. 15(1). 182–182. 12 indexed citations

12.

Lor, Mary, et al.. (2017). A mutant Tat protein inhibits infection of human cells by strains from diverse HIV-1 subtypes. Virology Journal. 14(1). 52–52. 8 indexed citations

13.

Li, Dongsheng, Haran Sivakumaran, Mary Lor, et al.. (2016). Shutdown of HIV-1 Transcription in T Cells by Nullbasic, a Mutant Tat Protein. mBio. 7(4). 17 indexed citations

14.

Leveque, Lucie, Therese Vu, Katie E. Lineburg, et al.. (2015). Autophagy is required for stem cell mobilization by G-CSF. Blood. 125(19). 2933–2936. 36 indexed citations

15.

Zhang, Ping, Siok‐Keen Tey, Motoko Koyama, et al.. (2013). Induced Regulatory T Cells Promote Tolerance When Stabilized by Rapamycin and IL-2 In Vivo. The Journal of Immunology. 191(10). 5291–5303. 90 indexed citations

16.

Leveque, Lucie, Therese Vu, Rachel D. Kuns, et al.. (2013). Autophagy Is Required For Long-Term Hematopoietic Stem Cell (HSC) Function and G-CSF-Induced HSC Mobilization. Blood. 122(21). 892–892. 1 indexed citations

17.

Kennedy, Glen, Antiopi Varelias, Slavica Vučković, et al.. (2013). The Addition Of Interleukin-6 Inhibition To Standard Gvhd Prophylaxis Prevents Acute Gvhd: Interim Results Of a Phase I/II Clinical Study. Blood. 122(21). 908–908. 4 indexed citations

18.

Koyama, Motoko, Rachel D. Kuns, Stuart D. Olver, et al.. (2013). Promoting regulation via the inhibition of DNAM-1 after transplantation. Blood. 121(17). 3511–3520. 39 indexed citations

19.

Kuns, Rachel D., Stuart D. Olver, Katie E. Lineburg, et al.. (2012). Promoting Regulation Via the Inhibition of DNAM-1 After Transplantation. Blood. 120(21). 338–338. 3 indexed citations

20.

Coulthard, Liam G., et al.. (2010). Complement expression in mice throughout neural tube closure. Molecular Immunology. 47(13). 2251–2251. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact